Maspin: molecular mechanisms and therapeutic implications

[1]  A. Chambers,et al.  An emerging role for the nuclear localization of maspin in the suppression of tumor progression and metastasis. , 2012, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[2]  Yi-fei Wang,et al.  [Interaction of SerpinB5 and MAFbx in gastric cancer cell and its action site]. , 2012, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.

[3]  Young-Joon Kim,et al.  Genome-Wide Analysis of DNA Methylation and the Gene Expression Change in Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  E. Yamamoto,et al.  Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors. , 2011, Oncology reports.

[5]  Stephanie Alexander,et al.  Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.

[6]  H. Jang,et al.  Maspin increases Ku70 acetylation and Bax-mediated cell death in cancer cells. , 2011, International journal of molecular medicine.

[7]  Bingya Liu,et al.  SerpinB5 interacts with KHDRBS3 and FBXO32 in gastric cancer cells. , 2011, Oncology reports.

[8]  L. Giacomelli,et al.  Nuclear MASPIN expression relates to a better prognosis in elderly patients with laryngeal carcinoma , 2011, Acta oto-laryngologica.

[9]  H. Bernstein,et al.  Maspin is a deoxycholate-inducible, anti-apoptotic stress-response protein differentially expressed during colon carcinogenesis , 2011, Clinical and experimental gastroenterology.

[10]  Yibin Kang,et al.  Unravelling the complexity of metastasis — molecular understanding and targeted therapies , 2011, Nature Reviews Cancer.

[11]  S. Ghazy,et al.  Maspin and MCM2 immunoprofiling in salivary gland carcinomas , 2011, Diagnostic pathology.

[12]  J. Huntington.  Serpin structure, function and dysfunction , 2011, Journal of thrombosis and haemostasis : JTH.

[13]  Yanqiu Hu,et al.  Maspin, the Molecular Bridge between the Plasminogen Activator System and β1 Integrin That Facilitates Cell Adhesion* , 2011, The Journal of Biological Chemistry.

[14]  V. Giguère,et al.  Nuclear localization of maspin is essential for its inhibition of tumor growth and metastasis , 2011, Laboratory Investigation.

[15]  A. Tanimoto,et al.  Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer , 2011, Diagnostic pathology.

[16]  S. Mirza,et al.  Identification of phosphorylation sites on extracellular corneal epithelial cell maspin , 2011, Proteomics.

[17]  I. Campbell,et al.  Integrin structure, activation, and interactions. , 2011, Cold Spring Harbor perspectives in biology.

[18]  P. Blancafort,et al.  Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs) , 2011, Epigenetics.

[19]  N. Sugino,et al.  Evidence of post-translational modification of the tumor suppressor maspin under oxidative stress. , 2011, International journal of molecular medicine.

[20]  S. Mirza,et al.  Clinical significance of Maspin promoter methylation and loss of its protein expression in invasive ductal breast carcinoma: correlation with VEGF-A and MTA1 expression , 2011, Tumor Biology.

[21]  M. Bar‐eli,et al.  Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype , 2010, Proceedings of the National Academy of Sciences.

[22]  P. Surowiak,et al.  Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma. , 2010, Folia morphologica.

[23]  R. Ghosh,et al.  Acetyl salicyclic acid (aspirin) improves synthesis of maspin and lowers incidence of metastasis in breast cancer patients , 2010, Cancer science.

[24]  V. Ellis,et al.  G-helix of Maspin Mediates Effects on Cell Migration and Adhesion* , 2010, The Journal of Biological Chemistry.

[25]  L. Qin,et al.  Maspin Regulates Endothelial Cell Adhesion and Migration through an Integrin Signaling Pathway* , 2010, The Journal of Biological Chemistry.

[26]  L. Giacomelli,et al.  Expression of MASPIN and angiogenin in nasopharyngeal carcinoma: Novel preliminary clinico-pathological evidence , 2010, Acta oto-laryngologica.

[27]  R. Herrmann,et al.  Shift from cytoplasmic to nuclear maspin expression correlates with shorter overall survival in node-negative colorectal cancer. , 2010, Human pathology.

[28]  W. Jonat,et al.  Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer. , 2010, Anticancer research.

[29]  S. Choi,et al.  Aberrant maspin expression is involved in early carcinogenesis of gallbladder cancer , 2010, Tumor Biology.

[30]  Byoung-Gie Kim,et al.  Interaction of testisin with maspin and its impact on invasion and cell death resistance of cervical cancer cells , 2010, FEBS letters.

[31]  H. Mehdorn,et al.  Expression of metastasis suppressor gene maspin is reduced in breast cancer brain metastases and correlates with the estrogen receptor status , 2010, Neurological research.

[32]  Chaehwa Park,et al.  Maspin suppresses survival of lung cancer cells through modulation of Akt pathway. , 2010, Cancer research and treatment : official journal of Korean Cancer Association.

[33]  H. Ozguc,et al.  Maspin expression in gastrointestinal stromal tumors , 2010, World journal of surgical oncology.

[34]  D. Ginsberg,et al.  The Tumor Suppressor Maspin Mediates E2F1-Induced Sensitivity of Cancer Cells to Chemotherapy , 2010, Molecular Cancer Research.

[35]  Phillip Koeffler,et al.  Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation , 2010, BMC Cancer.

[36]  M. Molloy,et al.  Clinicopathological correlates and prognostic significance of maspin expression in 450 patients after potentially curative resection of node‐positive colonic cancer , 2010, Histopathology.

[37]  J. Whisstock,et al.  Maspin (SERPINB5) Is an Obligate Intracellular Serpin* , 2010, The Journal of Biological Chemistry.

[38]  L. Giacomelli,et al.  Laryngeal carcinoma lymph node metastasis and disease-free survival correlate with MASPIN nuclear expression but not with EGFR expression: a series of 108 cases , 2010, European Archives of Oto-Rhino-Laryngology.

[39]  P. Heikkilä,et al.  High expression of maspin is associated with early tumor relapse in breast cancer. , 2009, Human pathology.

[40]  V. Ellis,et al.  Binding of Extracellular Maspin to β1 Integrins Inhibits Vascular Smooth Muscle Cell Migration* , 2009, The Journal of Biological Chemistry.

[41]  E. Yamamoto,et al.  Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[42]  A. Chambers,et al.  MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? , 2009, Cancer research.

[43]  M. Hendrix,et al.  Temporal and spatial expression patterns for the tumor suppressor Maspin and its binding partner interferon regulatory factor 6 during breast development , 2009, Development, growth & differentiation.

[44]  J. Arbiser,et al.  Maspin expression, angiogenesis, prognostic parameters, and outcome in malignant melanoma. , 2009, Journal of the American Academy of Dermatology.

[45]  J. Emerich,et al.  Maspin overexpression correlates with positive response to primary chemotherapy in ovarian cancer patients. , 2009, Gynecologic oncology.

[46]  S. Sheng,et al.  Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF‐A levels and in Stage I, improved survival , 2009, Histopathology.

[47]  Karen E. Pollok,et al.  PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells , 2009, Cell cycle.

[48]  Ying Ma,et al.  [Expression of maspin and its relation to tumor vascularization in epithelian ovarian cancer]. , 2009, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[49]  J. Glod,et al.  Targeting the tumor stroma in cancer therapy. , 2009, Current pharmaceutical biotechnology.

[50]  A. Porter,et al.  Focused PCR Screen Reveals p53 Dependence of Nitric Oxide-Induced Apoptosis and Up-Regulation of Maspin and Plasminogen Activator Inhibitor-1 in Tumor Cells , 2009, Molecular Cancer Research.

[51]  L. Giacomelli,et al.  MASPIN's prognostic role in patients with advanced head and neck carcinoma treated with primary chemotherapy (carboplatin plus vinorelbine) and radiotherapy: preliminary evidence , 2009, Acta oto-laryngologica.

[52]  A. Staffieri,et al.  MASPIN tumour-suppressing activity in head and neck squamous cell carcinoma: Emerging evidence and therapeutic perspectives , 2009, Acta oto-laryngologica.

[53]  Wei Li,et al.  [The expression of Maspin protein in oral squamous cell carcinoma and its significance]. , 2008, Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology.

[54]  Y. Yi,et al.  [Construction of a eukaryotic vector expressing MASPIN gene and its effect on cell apoptosis in gastric cancer cell line SGC7901]. , 2008, Ai zheng = Aizheng = Chinese journal of cancer.

[55]  T. Johnson-Pais,et al.  Maspin reduces prostate cancer metastasis to bone. , 2008, Urologic oncology.

[56]  T. Abiko,et al.  Expression of maspin in non-small-cell lung cancer: correlation with clinical features. , 2008, Clinical lung cancer.

[57]  F. Kayaselçuk,et al.  Maspin, E-selectin, and P-selectin expressions in papillary thyroid carcinomas and their correlation with prognostic parameters. , 2008, Pathology, research and practice.

[58]  Hua-Chuan Zheng,et al.  Cytoplasmic and Nuclear Maspin Expression in Lung Carcinomas: An Immunohistochemical Study Using Tissue Microarrays , 2008, Applied immunohistochemistry & molecular morphology : AIMM.

[59]  L. Cantley,et al.  PI3K pathway alterations in cancer: variations on a theme , 2008, Oncogene.

[60]  M. Hendrix,et al.  IFN‐γ regulation of vacuolar pH, cathepsin D processing and autophagy in mammary epithelial cells , 2008, Journal of cellular biochemistry.

[61]  G. Ayala,et al.  Haploinsufficiency of the maspin tumor suppressor gene leads to hyperplastic lesions in prostate. , 2008, Cancer research.

[62]  F. Kayaselçuk,et al.  Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma. , 2008, Pathology, research and practice.

[63]  T. Ettl,et al.  Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors. , 2008, Oral oncology.

[64]  P. Lizardi,et al.  Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor , 2008, Molecular Cancer Therapeutics.

[65]  L. Giacomelli,et al.  Nuclear localization of mammary serine protease inhibitor (MASPIN): is its impact on the prognosis in laryngeal carcinoma due to a proapoptotic effect? , 2008, American journal of otolaryngology.

[66]  Anil Potti,et al.  An Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer , 2008, PloS one.

[67]  Mark A Horswill,et al.  Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fibroblasts. , 2008, Experimental eye research.

[68]  T. Morohoshi,et al.  Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas. , 2008, Hepatobiliary & pancreatic diseases international : HBPD INT.

[69]  J. Licht,et al.  ATF-2 controls transcription of Maspin and GADD45α genes independently from p53 to suppress mammary tumors , 2008, Oncogene.

[70]  Mary J. C. Hendrix,et al.  Interferon Regulatory Factor 6 Promotes Cell Cycle Arrest and Is Regulated by the Proteasome in a Cell Cycle-Dependent Manner , 2008, Molecular and Cellular Biology.

[71]  C. Cohen,et al.  Maspin and Mutant p53 Expression in Malignant Melanoma and Carcinoma: Use of Tissue Microarray , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[72]  Hyung-Seok Kim,et al.  Maspin and p53 Protein Expression in Gastric Adenocarcinoma and Its Clinical Applications , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[73]  T. Douchi,et al.  Maspin expression is up‐regulated during the progression of endometrioid endometrial carcinoma , 2007, Histopathology.

[74]  F. Carinci,et al.  Maspin Expression in Oral Squamous Cell Carcinoma , 2007, The Journal of craniofacial surgery.

[75]  David A. Tuveson,et al.  Maximizing mouse cancer models , 2007, Nature Reviews Cancer.

[76]  Yiwei Li,et al.  Maspin augments proteasome inhibitor‐induced apoptosis in prostate cancer cells , 2007, Journal of cellular physiology.

[77]  K. Tsuneyama,et al.  Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression. , 2007, Human pathology.

[78]  R. Toillon,et al.  Proteomics Demonstration That Normal Breast Epithelial Cells Can Induce Apoptosis of Breast Cancer Cells through Insulin-like Growth Factor-binding Protein-3 and Maspin* , 2007, Molecular & Cellular Proteomics.

[79]  Dong-lin Wang,et al.  [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma]. , 2007, Ai zheng = Aizheng = Chinese journal of cancer.

[80]  R. Hruban,et al.  Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases , 2007, Modern Pathology.

[81]  S. Eccles,et al.  Metastasis: recent discoveries and novel treatment strategies , 2007, The Lancet.

[82]  Mingyao Liu,et al.  Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase. , 2007, Cell motility and the cytoskeleton.

[83]  B. Cuevas,et al.  Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors , 2007, Oncogene.

[84]  M. Hendrix,et al.  Elucidating the function of secreted maspin: inhibiting cathepsin D-mediated matrix degradation. , 2007, Cancer research.

[85]  Yang Jiang,et al.  [Expression of maspin protein and correlation between maspin and P53 proteins in gastric carcinoma]. , 2007, Zhonghua yi xue za zhi.

[86]  A. Bosserhoff,et al.  Loss of maspin expression contributes to a more invasive potential in malignant melanoma. , 2007, Pigment cell research.

[87]  H. Son,et al.  Prognostic significance of maspin expression in human gastric adenocarcinoma. , 2007, Hepato-gastroenterology.

[88]  L. Giacomelli,et al.  Maspin expression in adenocarcinoma of the ampulla of Vater: relation with clinicopathological parameters and apoptosis. , 2007, Anticancer research.

[89]  A. Bhardwaj,et al.  Maspin is Useful in the Distinction of Pancreatic Adenocarcinoma From Chronic Pancreatitis: A Tissue Microarray Based Study , 2007, Applied immunohistochemistry & molecular morphology : AIMM.

[90]  K. Jung,et al.  Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF). , 2007, Oral oncology.

[91]  Frederick Y. Wu,et al.  Convergence of p53 and Transforming Growth Factor β (TGFβ) Signaling on Activating Expression of the Tumor Suppressor Gene maspin in Mammary Epithelial Cells* , 2007, Journal of Biological Chemistry.

[92]  Y. Wong,et al.  Expression of maspin in endometrioid adenocarcinoma of endometrium. , 2007, Oncology reports.

[93]  Z. Khalkhali‐Ellis.  Maspin: The New Frontier , 2006, Clinical Cancer Research.

[94]  M. Hendrix,et al.  Biological functions of maspin , 2006, Journal of cellular physiology.

[95]  L. Giacomelli,et al.  Maspin nuclear localization is related to reduced density of tumour-associated micro-vessels in laryngeal carcinoma. , 2006, Anticancer research.

[96]  P. Crafa,et al.  The associated expression of Maspin and Bax proteins as a potential prognostic factor in intrahepatic cholangiocarcinoma , 2006, BMC Cancer.

[97]  A. Madan,et al.  Epigenetic regulation of maspin expression in the human placenta. , 2006, Molecular human reproduction.

[98]  H. Wada,et al.  Maspin Expression and Its Clinical Significance in Non-Small Cell Lung Cancer , 2006, Annals of Surgical Oncology.

[99]  S. Sheng,et al.  Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. , 2006, Cancer research.

[100]  L. Giacomelli,et al.  Nuclear maspin detection in renal cell tumours: possible diagnostic role and correlation with p53 status , 2006, Histopathology.

[101]  R. Samaka,et al.  Maspin protein expression: a special feature of papillary thyroid carcinoma. , 2006, Journal of the Egyptian National Cancer Institute.

[102]  F. Domann,et al.  Epigenetic regulation of maspin expression in human ovarian carcinoma cells. , 2006, Gynecologic oncology.

[103]  D. Jonas,et al.  Clinical relevance of maspin expression in bladder cancer , 2006, World Journal of Urology.

[104]  J. Rosen,et al.  Maspin Is Physically Associated with ␤1 Integrin Regulating Cell Adhesion in Mammary Epithelial Cells , 2022 .

[105]  T. Athanasiou,et al.  Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer , 2006, Journal of Clinical Pathology.

[106]  A. Munkarah,et al.  Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer. , 2006, Gynecologic oncology.

[107]  A. Berchuck,et al.  Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study. , 2006, Gynecologic oncology.

[108]  J. Whisstock,et al.  An overview of the serpin superfamily , 2006, Genome Biology.

[109]  L. Bubendorf,et al.  Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer , 2006, Journal of Clinical Pathology.

[110]  B. Tang,et al.  [Transcription regulation of 5-Aza-2'-deoxycytidine on maspin gene demethylation in RKO human colorectal cell line]. , 2006, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.

[111]  A. Levine,et al.  The regulation of exosome secretion: a novel function of the p53 protein. , 2006, Cancer research.

[112]  A. Hartmann,et al.  Nuclear Maspin expression is associated with response to adjuvant 5‐fluorouracil based chemotherapy in patients with stage III colon cancer , 2006, International journal of cancer.

[113]  A. Cheung,et al.  Expression of maspin in gestational trophoblastic disease. , 2006, Gynecologic oncology.

[114]  Mi-ja Lee,et al.  Clinicopathological Significance of Maspin Expression in Breast Cancer , 2006, Journal of Korean medical science.

[115]  M. Dietel,et al.  Maspin Expression Is Characteristic for Cisplatin-Sensitive Ovarian Cancer Cells and for Ovarian Cancer Cases of Longer Survival Rates , 2006, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[116]  R. Finley,et al.  Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. , 2006, The Journal of biological chemistry.

[117]  T. Iwaya,et al.  Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis , 2006, Journal of Clinical Pathology.

[118]  G. Bhattacharya,et al.  The role of insulin dependent NO synthesis in the impaired production of maspin in human breast cancer , 2006, Journal of Cancer Research and Clinical Oncology.

[119]  K. Hunter,et al.  Host genetics influence tumour metastasis , 2006, Nature Reviews Cancer.

[120]  G. Bhattacharya,et al.  Restoration by aspirin of impaired plasma maspin level in human breast cancer , 2006, Acta oncologica.

[121]  M. Heenen,et al.  Decreased Immunoreactive Maspin Expression in Intermediate Thickness and Thick Primary Melanoma Lesions , 2006, The Journal of international medical research.

[122]  A. Altemani,et al.  Maspin expression in carcinoma ex pleomorphic adenoma , 2005, Journal of Clinical Pathology.

[123]  Chunming Ding,et al.  Detection of the placental epigenetic signature of the maspin gene in maternal plasma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[124]  M. Hendrix,et al.  Mammary Serine Protease Inhibitor (Maspin) Binds Directly to Interferon Regulatory Factor 6 , 2005, Journal of Biological Chemistry.

[125]  M. A. El-Wahed.  Expression and subcellular localization of maspin in human ovarian epithelial neoplasms: correlation with clinicopathologic features. , 2005 .

[126]  E. Nam,et al.  Expression of maspin is associated with the intestinal type of gastric adenocarcinoma. , 2005, Cancer research and treatment : official journal of Korean Cancer Association.

[127]  C. Sung,et al.  Maspin expression in CIN 3, microinvasive squamous cell carcinoma, and invasive squamous cell carcinoma of the uterine cervix , 2005, Modern Pathology.

[128]  J. Whisstock,et al.  The High Resolution Crystal Structure of the Human Tumor Suppressor Maspin Reveals a Novel Conformational Switch in the G-helix* , 2005, Journal of Biological Chemistry.

[129]  Qi Dong,et al.  [Effects of microencapsulated CHO cells modified with maspin gene on the motility and adhesiveness of breast carcinoma cells Bcap37]. , 2005, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[130]  Ming Zhang,et al.  Maspin overexpression modulates tumor cell apoptosis through the regulation of Bcl-2 family proteins , 2005, BMC Cancer.

[131]  L. Giacomelli,et al.  Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease‐free interval after surgery for squamous cell carcinoma of the larynx , 2005, Histopathology.

[132]  K. Engeland,et al.  TAp63γ can substitute for p53 in inducing expression of the maspin tumor suppressor , 2005, International journal of cancer.

[133]  A. Hartmann,et al.  Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer , 2005, The Journal of pathology.

[134]  H. Daida,et al.  Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth. , 2005, Human gene therapy.

[135]  Ming Zhang,et al.  Targeted expression of maspin in tumor vasculatures induces endothelial cell apoptosis , 2005, Oncogene.

[136]  M. Shirane,et al.  Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis , 2005, British Journal of Cancer.

[137]  Ming Zhang,et al.  Maspin Mediates Increased Tumor Cell Apoptosis upon Induction of the Mitochondrial Permeability Transition , 2005, Molecular and Cellular Biology.

[138]  Noriyuki Nakatsu,et al.  Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays , 2005, Molecular Cancer Therapeutics.

[139]  C. Boltze.  Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis. , 2005, Pathology, research and practice.

[140]  Kazuyoshi Saito,et al.  Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas , 2005, Laboratory Investigation.

[141]  K. Volz,et al.  Crystal Structure of Human Maspin, a Serpin with Antitumor Properties , 2004, Journal of Biological Chemistry.

[142]  Kazuhiro Yoshida,et al.  Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality. , 2004, Oncology reports.

[143]  Joungho Han,et al.  Maspin Expression Is Transactivated by p63 and Is Critical for the Modulation of Lung Cancer Progression , 2004, Cancer Research.

[144]  A. Miyauchi,et al.  Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma. , 2004, Thyroid : official journal of the American Thyroid Association.

[145]  M. Hendrix,et al.  Aberrant methylation of the maspin promoter is an early event in human breast cancer. , 2004, Neoplasia.

[146]  N. Matsubara,et al.  Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines. , 2004, Oral oncology.

[147]  M. Adachi,et al.  Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma , 2004, Journal of Cancer Research and Clinical Oncology.

[148]  Z. Nawaz,et al.  Tamoxifen induces the expression of maspin through estrogen receptor-alpha. , 2004, Cancer letters.

[149]  H. Huland,et al.  Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis. , 2004, European urology.

[150]  Y. Yatabe,et al.  Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation , 2004, Oncogene.

[151]  I. Roninson,et al.  Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. , 2004, Cancer research.

[152]  F. Gao,et al.  Maspin plays an essential role in early embryonic development , 2004, Development.

[153]  Yan Li,et al.  Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer. , 2004, World journal of gastroenterology.

[154]  S. Sheng,et al.  Bax Mediates the Apoptosis-Sensitizing Effect of Maspin , 2004, Cancer Research.

[155]  T. Masuda,et al.  Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells. , 2004, The Journal of investigative dermatology.

[156]  Kazuyoshi Saito,et al.  Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers , 2004, Oncogene.

[157]  M. Hendrix,et al.  Regulating the Tumor Suppressor Gene Maspin in Breast Cancer Cells , 2004, Clinical Cancer Research.

[158]  Robert A. Weinberg,et al.  Comparative Biology of Mouse versus Human Cells: Modelling Human Cancer in Mice O P I N I O N , 2022 .

[159]  J. Heighway,et al.  Maspin – the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer – is strongly expressed in preneoplastic bronchial lesions , 2003, Oncogene.

[160]  R. Schneider-Stock,et al.  Maspin in thyroid cancer: its relationship with p53 and clinical outcome. , 2003, Oncology reports.

[161]  T. Masuda,et al.  Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. , 2003, The American journal of pathology.

[162]  R. Hinze,et al.  Silencing of the maspin gene by promoter hypermethylation in thyroid cancer. , 2003, International journal of molecular medicine.

[163]  H. Duan,et al.  MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells. , 2003, Antioxidants & redox signaling.

[164]  W. Jonat,et al.  Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. , 2003, Cancer letters.

[165]  Shijie Sheng,et al.  Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis , 2003, Oncogene.

[166]  F. Domann,et al.  Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control. , 2003, Neoplasia.

[167]  J. Burke,et al.  Sufficiency of the Reactive Site Loop of Maspin for Induction of Cell-Matrix Adhesion and Inhibition of Cell Invasion , 2003, Journal of Biological Chemistry.

[168]  S. Sheng,et al.  Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[169]  H. Yoshida,et al.  Expression of maspin is up‐regulated during the progression of mammary ductal carcinoma , 2003, Histopathology.

[170]  M. Hendrix,et al.  Nitric oxide regulation of maspin expression in normal mammary epithelial and breast cancer cells. , 2003, The American journal of pathology.

[171]  G. Clark,et al.  Maspin expression in invasive breast cancer: association with other prognostic factors , 2003, The Journal of pathology.

[172]  I. Bièche,et al.  Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas , 2003, British Journal of Cancer.

[173]  N. Greenberg,et al.  Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells. , 2003, The Journal of urology.

[174]  J. Sohn,et al.  Association of maspin expression with the high histological grade and lymphocyte‐rich stroma in early‐stage breast cancer , 2003, Histopathology.

[175]  V. Ellis,et al.  Maspin Inhibits Cell Migration in the Absence of Protease Inhibitory Activity* , 2002, The Journal of Biological Chemistry.

[176]  W. Jonat,et al.  Expression and regulation of tumor suppressor gene maspin in breast cancer. , 2002, Clinical breast cancer.

[177]  F. Rösel,et al.  Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. , 2002, Biochemical and biophysical research communications.

[178]  W. Lee,et al.  Expression of Maspin in Colon Cancers: Its Relationship with p53 Expression and Microvessel Density , 2002, Digestive Diseases and Sciences.

[179]  T. Sohn,et al.  Maspin expression in human gastric adenocarcinoma , 2002, Pathology international.

[180]  Y. Sagara,et al.  Expression of maspin predicts poor prognosis in breast‐cancer patients , 2002, International journal of cancer.

[181]  M. Hendrix,et al.  Tyrosine phosphorylation of maspin in normal mammary epithelia and breast cancer cells. , 2002, Biochemical and biophysical research communications.

[182]  S. Sheng,et al.  Maspin sensitizes breast carcinoma cells to induced apoptosis , 2002, Oncogene.

[183]  Ming Zhang,et al.  Tissue microarray analysis of maspin expression and its reverse correlation with mutant p53 in various tumors. , 2002, International journal of oncology.

[184]  Hong Duan,et al.  Role for DNA methylation in the control of cell type–specific maspin expression , 2002, Nature Genetics.

[185]  C. Streuli.  Maspin is a tumour suppressor that inhibits breast cancer tumour metastasis in vivo , 2002, Breast Cancer Research.

[186]  M. Hendrix,et al.  The tumour suppressor gene maspin is differentially regulated in cytotrophoblasts during human placental development. , 2002, Placenta.

[187]  H. Biliran,et al.  Pleiotrophic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. , 2001, Cancer research.

[188]  J. Burke,et al.  Maspin: synthesis by human cornea and regulation of in vitro stromal cell adhesion to extracellular matrix. , 2001, Investigative Ophthalmology and Visual Science.

[189]  T. Nakashima,et al.  Maspin expression in stage I and II oral tongue squamous cell carcinoma , 2001, Head & neck.

[190]  S. Sheng,et al.  Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model , 2001, Oncogene.

[191]  F. Rösel,et al.  Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast , 2001, The Journal of pathology.

[192]  F. Kittrell,et al.  Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. , 2001, Cancer research.

[193]  J. Mesirov,et al.  Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[194]  K. Yamaguchi,et al.  Association of maspin expression with the malignancy grade and tumor vascularization in breast cancer tissues. , 2001, Cancer letters.

[195]  F. Rösel,et al.  Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. , 2001, Clinical biochemistry.

[196]  P. Furth,et al.  Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice , 2000, Oncogene.

[197]  J. Serth,et al.  P53 regulated maspin protein expression determines recurrence-free survival of patients with localised prostate cancer , 2000, Prostate Cancer and Prostatic Diseases.

[198]  S. Barsky,et al.  Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. , 2000, Cancer letters.

[199]  R. Sager,et al.  The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. , 2000, Cancer research.

[200]  T. Nakashima,et al.  Genomic cloning, mapping, structure and promoter analysis of HEADPIN, a serpin which is down-regulated in head and neck cancer cells. , 2000, Biochimica et biophysica acta.

[201]  D. Johnston,et al.  High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma , 2000, Oncogene.

[202]  M. Hendrix,et al.  Epigenetic silencing of maspin gene expression in human breast cancers , 2000, International journal of cancer.

[203]  E. Appella,et al.  p53 Regulates the Expression of the Tumor Suppressor Gene Maspin* , 2000, The Journal of Biological Chemistry.

[204]  Z. Gatalica,et al.  Immunohistochemical detection of maspin is a useful adjunct in distinguishing radial sclerosing lesion from tubular carcinoma of the breast. , 2000, Applied immunohistochemistry & molecular morphology : AIMM.

[205]  O. Volpert,et al.  Maspin is an angiogenesis inhibitor , 2000, Nature Medicine.

[206]  J. Irving,et al.  Human ovalbumin serpin evolution: phylogenic analysis, gene organization, and identification of new PI8-related genes suggest that two interchromosomal and several intrachromosomal duplications generated the gene clusters at 18q21-q23 and 6p25. , 1999, Genomics.

[207]  P. Furth,et al.  Maspin plays an important role in mammary gland development. , 1999, Developmental biology.

[208]  A. D. Robertson,et al.  Three-state Unfolding and Self-association of Maspin, a Tumor-suppressing Serpin* , 1999, The Journal of Biological Chemistry.

[209]  L. Taichman,et al.  A partial catalog of proteins secreted by epidermal keratinocytes in culture. , 1999, The Journal of investigative dermatology.

[210]  Z. Shen,et al.  [Human breast myoepithelial cell blocks estrogen receptor-negative breast carcinoma cell invasion]. , 1999, Zhonghua yi xue za zhi.

[211]  M. Hendrix,et al.  maspin suppresses the invasive phenotype of human breast carcinoma. , 1998, Cancer research.

[212]  G. Silverman,et al.  SCCA1 and SCCA2 Are Proteinase Inhibitors That Map to the Serpin Cluster at 18q21.3 , 1998, Tumor Biology.

[213]  Z. Shao,et al.  The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. , 1998, Experimental cell research.

[214]  B. Spiegelman,et al.  Terminal differentiation of human breast cancer through PPAR gamma. , 1998, Molecular cell.

[215]  A. Pardee,et al.  Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[216]  J. R. Erickson,et al.  Maspin Is an Intracellular Serpin That Partitions into Secretory Vesicles and Is Present at the Cell Surface , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[217]  Z. Shao,et al.  The human myoepithelial cell is a natural tumor suppressor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[218]  R. Mansel,et al.  Gamma linolenic acid regulates expression of maspin and the motility of cancer cells. , 1997, Biochemical and biophysical research communications.

[219]  G. Silverman,et al.  Cytoplasmic antiproteinase 2 (PI8) and bomapin (PI10) map to the serpin cluster at 18q21.3. , 1997, Genomics.

[220]  R. Sager,et al.  Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[221]  R. Hiipakka,et al.  Rat and human maspins: structures, metastatic suppressor activity and mutation in prostate cancer cells. , 1997, Cancer letters.

[222]  R. Sager,et al.  Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[223]  M. Hendrix,et al.  Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[224]  D. Wong,et al.  Functional implications of the modeled structure of maspin. , 1996, Protein engineering.

[225]  A. Jetten,et al.  Gamma-interferon induces an irreversible growth arrest in mid-G1 in mammary epithelial cells which correlates with a block in hyperphosphorylation of retinoblastoma. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[226]  D. Wong,et al.  The Tumor Suppressor Maspin Does Not Undergo the Stressed to Relaxed Transition or Inhibit Trypsin-like Serine Proteases. , 1995, The Journal of Biological Chemistry.

[227]  R. Sager,et al.  Production, purification, and characterization of recombinant maspin proteins. , 1994, The Journal of biological chemistry.

[228]  J. Whisstock,et al.  Function of maspin. , 1994, Science.

[229]  M. Hendrix,et al.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. , 1994, Science.

[230]  H. Rochefort,et al.  Increased secretion, altered processing, and glycosylation of pro-cathepsin D in human mammary cancer cells. , 1989, Cancer research.

[231]  H. Rochefort,et al.  Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. , 1986, Endocrinology.

[232]  M. Hendrix,et al.  Maspin suppresses breast cancer cell invasiveness by modulating integrin expression and function , 2013 .

[233]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[234]  S. Twining,et al.  Focus on molecules: maspin. , 2010, Experimental eye research.

[235]  Qing‐Yu He,et al.  Mammary serine protease inhibitor inhibits epithelial growth factor‐induced epithelial‐mesenchymal transition of esophageal carcinoma cells , 2009, Cancer.

[236]  L. Giacomelli,et al.  Expression of maspin in papillary Ta/T1 bladder neoplasms. , 2008, Anticancer research.

[237]  Kon-Ho Lee,et al.  Maspin polymorphism associated with apoptosis susceptibility and in vivo tumorigenesis. , 2008, International journal of molecular medicine.

[238]  K. Tsuneyama,et al.  Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors. , 2007, Anticancer research.

[239]  中嶋 大.  Protein expression profiling identifies maspin and stathmin as potential biomarkers of adenoid cystic carcinoma of the salivary glands , 2007 .

[240]  S. Sheng,et al.  Maspin nuclear localization is linked to favorable morphological features in pulmonary adenocarcinoma. , 2006, Lung cancer.

[241]  M. Sopel,et al.  Maspin and c-erbB-2 expression in correlation with microvessel density in invasive ductal breast cancer. , 2005, Folia histochemica et cytobiologica.

[242]  A. Maitra,et al.  Aberrant expression of maspin in idiopathic inflammatory bowel disease is associated with disease activity and neoplastic transformation , 2005, International journal of gastrointestinal cancer.

[243]  T. Jacks.  Modeling cancer in the mouse. , 2005, Harvey lectures.

[244]  W. Jonat,et al.  Expression and regulation of tumor suppressor gene maspin in human bladder cancer. , 2004, Cancer letters.

[245]  H. Lehnert,et al.  [Role of the class II tumor suppressor gene maspin in thyroid carcinogenesis]. , 2004, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[246]  M. Hendrix,et al.  Molecular Role(s) for Integrins in Human Melanoma Invasion , 2004, Cancer and Metastasis Reviews.

[247]  Yanxin,et al.  EXPRESSION OF MASPIN AND KAI1 AND THEIR CLINICOPATHOLOGICAL SIGNIFICANCE IN CARCINOGENESIS AND PROGRESSION OF GASTRIC CANCER , 2004 .

[248]  J. Reis-Filho,et al.  Maspin expression in myoepithelial tumors of the breast. , 2001, Pathology, research and practice.

[249]  S. Sheng,et al.  mMaspin: The Mouse Homolog of a Human Tumor Suppressor Gene Inhibits Mammary Tumor Invasion and Motility , 1997, Molecular medicine.

[250]  S. Barsky,et al.  The myoepithelial defense: a host defense against cancer. , 1997, Medical hypotheses.